RESMED INC — Director's Dealing 2010

Feb 12, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-02-11

Reporting Person: Douglas Robert Andrew (COO Asia Pacific)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-11	ResMed Common Stock	M	10000	$31.04	Acquired	11941.237	Direct
2010-02-11	ResMed Common Stock	S	10000	$54.8266	Disposed	1941.237	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-11	ResMed Common Stock Options	$31.04	M	10000	Disposed	2015-11-20	ResMed Common Stock (10000)	Direct

Footnotes

F1: Represents the first date the options became exercisable.

F2: Previous reports aggregated all beneficially owned derivative securities following the reported transaction. This report includes only beneficially owned derivative securities of the same class as those disposed of in this trade, meaning those that have the same grant date and exercise price.

F3: This transaction was executed in multiple trades at prices ranging from $54.81 to $54.87. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Includes 321.472 shares purchased on October 31, 2009, through ResMed's Employee Stock Purchase program.